Chloroquine against Covid-19?
The antimalarial drug, chloroquine has been claimed effective in the treatment of patients infected by the novel emerged coronavirus, Covid-19
A forum for researchers, students and applicants in the field of cyclodextrin technology
The antimalarial drug, chloroquine has been claimed effective in the treatment of patients infected by the novel emerged coronavirus, Covid-19
Following the great success of past ten years, BIT’s 11th World Gene Convention-2020 (WGC-2020) planned to be held on June
A recent review of Italian researchers emphasized the role of membrane lipids in the infectivity mechanism of SARS-COV-2 (Covid-19) based
Cyclo Therapeutics, Inc., a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of Niemann-Pick Disease Type C (NPC)
Coronavirus SARS-CoV caused an outbreak of severe acute respiratory syndrome (SARS) emerged in Guangdong Province, People’s Republic of China in
University Hospitals in Cleveland, US is set to conduct two clinical trials of remdesivir to treat adult Covid-19 patients hospitalised
Due to the reported high ability of virulence of COVID_19 in recent months, several studies have been conducted to discover
A paper has recently come out open-access in Biomacromolecules reporting on pH-Responsive Polymersome Microparticles as Smart Cyclodextrin-Releasing Agents (DOI: 10.1021/acs.biomac.9b01083).
The Scientific Committee of ICS2020 decided to postpone the International Cyclodextrin Symposium (ICS2020) organized by the National Council of Research
ICND 2020 is going to be held during April 15-17, 2020 in Radisson Narita, Tokyo, Japa in collaboration with European